SCHEMBL29404629

SCHEMBL29404629

O=[PH](O)CN1CCN(C[PH](=O)O)CCN(C[PH](=O)O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13510843 1.00 — —
SCHEMBL20067782 0.92 POLB (0.31) —
SCHEMBL5002585 0.83 HSD17B10 (0.47) —
SCHEMBL18539112 0.83 HSD17B10 (0.47) —
SCHEMBL28849785 0.56 — —
SCHEMBL439693 0.55 — —
SCHEMBL462272 0.55 — —
SCHEMBL2487813 0.55 — —
SCHEMBL10579614 0.53 — —
SCHEMBL437399 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116209433-A Small molecule albumin binding agents 俄勒冈健康科学大学 2023-06-02 — — CN claimed
WO-2022040607-A1 SMALL MOLECULE ALBUMIN BINDERS OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-02-24 — — WO claimed
US-20250360237-A1 TARGETING SYSTEM FOR CANCER TREATMENT Coretag IP B.V. (NL) 2025-11-27 — — US disclosed
EP-4615507-A1 TARGETING SYSTEM FOR CANCER TREATMENT Coretag IP B.V. (NL) 2025-09-17 — — EP disclosed
WO-2024101993-A1 TARGETING SYSTEM FOR CANCER TREATMENT Coretag IP B.V. (NL) 2024-05-16 — — WO disclosed
WO-2022040607-A1 SMALL MOLECULE ALBUMIN BINDERS OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-02-24 — — WO disclosed
Send feedback